AI in Medicine News ・ 💊 Drug discovery and clinical trials

QUANTRO Therapeutics Secures Austrian Research Grant To Expand AI-Powered Drug Discovery Platform

Pulse 2.0 · 11/08 14:42 UTC

Vienna-based QUANTRO Therapeutics, which develops medicines targeting transcription factors, has secured a 12-month non-dilutive research grant from the Austrian Research Promotion Agency (FFG). The grant is to accelerate development of its AI-powered medicinal chemistry platform, ASCEND.

Read the original (Pulse 2.0)

See it in the digest → ・ See this issue →